TY - JOUR
T1 - Clinical practice guidelines for duodenal cancer 2021
AU - Nakagawa, Kenji
AU - Sho, Masayuki
AU - Fujishiro, Mitsuhiro
AU - Kakushima, Naomi
AU - Horimatsu, Takahiro
AU - Okada, Ken ichi
AU - Iguchi, Mikitaka
AU - Uraoka, Toshio
AU - Kato, Motohiko
AU - Yamamoto, Yorimasa
AU - Aoyama, Toru
AU - Akahori, Takahiro
AU - Eguchi, Hidetoshi
AU - Kanaji, Shingo
AU - Kanetaka, Kengo
AU - Kuroda, Shinji
AU - Nagakawa, Yuichi
AU - Nunobe, Souya
AU - Higuchi, Ryota
AU - Fujii, Tsutomu
AU - Yamashita, Hiroharu
AU - Yamada, Suguru
AU - Narita, Yukiya
AU - Honma, Yoshitaka
AU - Muro, Kei
AU - Ushiku, Tetsuo
AU - Ejima, Yasuo
AU - Yamaue, Hiroki
AU - Kodera, Yasuhiro
N1 - Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12
Y1 - 2022/12
N2 - Duodenal cancer is considered to be a small intestinal carcinoma in terms of clinicopathology. In Japan, there are no established treatment guidelines based on sufficient scientific evidence; therefore, in daily clinical practice, treatment is based on the experience of individual physicians. However, with advances in diagnostic modalities, it is anticipated that opportunities for its detection will increase in future. We developed guidelines for duodenal cancer because this disease is considered to have a high medical need from both healthcare providers and patients for appropriate management. These guidelines were developed for use in actual clinical practice for patients suspected of having non-ampullary duodenal epithelial malignancy and for patients diagnosed with non-ampullary duodenal epithelial malignancy. In this study, a practice algorithm was developed in accordance with the Minds Practice Guideline Development Manual 2017, and Clinical Questions were set for each area of epidemiology and diagnosis, endoscopic treatment, surgical treatment, and chemotherapy. A draft recommendation was developed through a literature search and systematic review, followed by a vote on the recommendations. We made decisions based on actual clinical practice such that the level of evidence would not be the sole determinant of the recommendation. This guideline is the most standard guideline as of the time of preparation. It is important to decide how to handle each case in consultation with patients and their family, the treating physician, and other medical personnel, considering the actual situation at the facility (and the characteristics of the patient).
AB - Duodenal cancer is considered to be a small intestinal carcinoma in terms of clinicopathology. In Japan, there are no established treatment guidelines based on sufficient scientific evidence; therefore, in daily clinical practice, treatment is based on the experience of individual physicians. However, with advances in diagnostic modalities, it is anticipated that opportunities for its detection will increase in future. We developed guidelines for duodenal cancer because this disease is considered to have a high medical need from both healthcare providers and patients for appropriate management. These guidelines were developed for use in actual clinical practice for patients suspected of having non-ampullary duodenal epithelial malignancy and for patients diagnosed with non-ampullary duodenal epithelial malignancy. In this study, a practice algorithm was developed in accordance with the Minds Practice Guideline Development Manual 2017, and Clinical Questions were set for each area of epidemiology and diagnosis, endoscopic treatment, surgical treatment, and chemotherapy. A draft recommendation was developed through a literature search and systematic review, followed by a vote on the recommendations. We made decisions based on actual clinical practice such that the level of evidence would not be the sole determinant of the recommendation. This guideline is the most standard guideline as of the time of preparation. It is important to decide how to handle each case in consultation with patients and their family, the treating physician, and other medical personnel, considering the actual situation at the facility (and the characteristics of the patient).
KW - Clinical practice guidelines
KW - Duodenal cancer
KW - The Japan duodenal cancer guideline committee
KW - Treatment
UR - http://www.scopus.com/inward/record.url?scp=85140121272&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85140121272&partnerID=8YFLogxK
U2 - 10.1007/s00535-022-01919-y
DO - 10.1007/s00535-022-01919-y
M3 - Review article
C2 - 36260172
AN - SCOPUS:85140121272
SN - 0944-1174
VL - 57
SP - 927
EP - 941
JO - Journal of gastroenterology
JF - Journal of gastroenterology
IS - 12
ER -